Cited by 498

The DOI matches its Crossref record; 174 of the 174 references it cites were found in a registry or an index.

Protective and toxic roles of dopamine in Parkinson's disease

Open access

Segura‐Aguilar, Juan, Paris, Irmgard, Muñoz, Patricia, Ferrari, Emanuele, Zecca, Luigi, Zucca, Fabio A.·2014·Journal of Neurochemistry

DOI 10.1111/jnc.12686

Open this paper in CoChat — free account

Abstract

The molecular mechanisms causing the loss of dopaminergic neurons containing neuromelanin in the substantia nigra and responsible for motor symptoms of Parkinson's disease are still unknown. The discovery of genes associated with Parkinson's disease (such as alpha synuclein (SNCA), E3 ubiquitin protein ligase (parkin), DJ‐1 (PARK7), ubiquitin carboxyl‐terminal hydrolase isozyme L1 (UCHL‐1), serine/threonine‐protein kinase (PINK‐1), leucine‐rich repeat kinase 2 (LRRK2), cation‐transporting ATPase 13A1 (ATP13A), etc.) contributed enormously to basic research towards understanding the role of these proteins in the sporadic form of the disease. However, it is generally accepted by the scientific community that mitochondria dysfunction, alpha synuclein aggregation, dysfunction of protein degradation, oxidative stress and neuroinflammation are involved in neurodegeneration. Dopamine oxidation seems to be a complex pathway in which dopamine o‐quinone, aminochrome and 5,6‐indolequinone are formed. However, both dopamine o‐quinone and 5,6‐indolequinone are so unstable that is difficult to study and separate their roles in the degenerative process occurring in Parkinson's disease. Dopamine oxidation to dopamine o‐quinone, aminochrome and 5,6‐indolequinone seems to play an important role in the neurodegenerative processes of Parkinson's disease as aminochrome induces: (i) mitochondria dysfunction, (ii) formation and stabilization of neurotoxic protofibrils of alpha synuclein, (iii) protein degradation dysfunction of both proteasomal and lysosomal systems and (iv) oxidative stress. The neurotoxic effects of aminochrome in dopaminergic neurons can be inhibited by: (i) preventing dopamine oxidation of the transporter that takes up dopamine into monoaminergic vesicles with low pH and dopamine oxidative deamination catalyzed by monoamino oxidase (ii) dopamine o‐quinone, aminochrome and 5,6‐indolequinone polymerization to neuromelanin and (iii) two‐electron reduction of aminochrome catalyzed by DT‐diaphorase. Furthermore, dopamine conversion to NM seems to have a dual role, protective and toxic, depending mostly on the cellular context.image Dopamine oxidation to dopamine o‐quinone, aminochrome and 5,6‐indolequinone plays an important role in neurodegeneration in Parkinson's disease since they induce mitochondria and protein degradation dysfunction; formation of neurotoxic alpha synuclein protofibrils and oxidative stress. However, the cells have a protective system against dopamine oxidation composed by dopamine uptake mediated by Vesicular monoaminergic transporter‐2 (VMAT‐2), neuromelanin formation, two‐electron reduction and GSH‐conjugation mediated by Glutathione S‐transferase M2‐2 (GSTM2).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1111/jnc.12686

Cites

174 of 174 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism
Kitada, T., Asakawa, S., Hattori, N., Matsumine, H., Yamamura, Y., Minoshima, S., Yokochi, M., Mizuno, Y., & Shimizu, N. (1998) · Nature · doi:10.1038/33416 · Cited by 5,227
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110
Self-citation
Hereditary Early-Onset Parkinson's Disease Caused by Mutations in PINK1
Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S., Ali, Z., Del Turco, D., Bentivoglio, A. R., Healy, D. G., et al. (2004) · Science · doi:10.1126/science.1096284 · Cited by 3,481
Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism
Bonifati, V., Rizzu, P., van Baren, M. J., Schaap, O., Breedveld, G. J., Krieger, E., Dekker, M. C. J., Squitieri, F., Ibanez, P., Joosse, M., et al. (2003) · Science · doi:10.1126/science.1077209 · Cited by 2,778
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996) · Nature · doi:10.1038/379606a0 · Cited by 2,476
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 1×
“Finally, the formation of adducts of aminochrome with alpha synuclein inhibit chaperon-mediated autophagy (Cuervo et al. 2004); (iv) aminochrome induces oxidative stress when flavoenzymes catalyze its one-electron reduction to leucoaminochrome o-semiquinone radical (Fig.”
Background
Iron, brain ageing and neurodegenerative disorders
Zecca, L., Youdim, M. B. H., Riederer, P., Connor, J. R., & Crichton, R. R. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1537 · Cited by 1,801
Self-citation
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease
Hirsch, E., Graybiel, A. M., & Agid, Y. A. (1988) · Nature · doi:10.1038/334345a0 · Cited by 1,301 · cited 1×
“Indeed, Parkinson’s disease is characterized by preferential loss of those dopaminergic neurons that contain NM (Marsden 1983; Hirsch et al. 1988; Gibb and Lees 1991; Kastner et al. 1992).”
Background
Aggressive Behavior and Altered Amounts of Brain Serotonin and Norepinephrine in Mice Lacking MAOA
Cases, O., Seif, I., Grimsby, J., Gaspar, P., Chen, K., Pournin, S., Müller, U., Aguet, M., Babinet, C., Shih, J. C., et al. (1995) · Science · doi:10.1126/science.7792602 · Cited by 1,225
Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase
Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208
Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease
Dexter, D. T., Wells, F. R., Lee, A. J., Agid, F., Agid, Y., Jenner, P., & Marsden, C. D. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb07264.x · Cited by 1,149
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization
Canet-Avilés, R. M., Wilson, M. A., Miller, D. W., Ahmad, R., McLendon, C., Bandyopadhyay, S., Baptista, M. J., Ringe, D., Petsko, G. A., & Cookson, M. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402959101 · Cited by 1,116
Increased nigral iron content in postmortem parkinsonian brain
Dexter, D. T., Wells, F. R., Agid, F., Agid, Y., Lees, A. J., Jenner, P., & Marsden, C. D. (1987) · The Lancet · doi:10.1016/s0140-6736(87)91361-4 · Cited by 963
Autoxidation versus Covalent Binding of Quinones as the Mechanism of Toxicity of Dopamine, 6-Hydroxydopamine, and Related Compounds toward C1300 Neuroblastoma Cells in Vitro
GRAHAM, D. G., TIFFANY, S. M., BELL, W. R., & GUTKNECHT, W. F. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13536-0 · Cited by 953
Mitochondrial dysfunction and oxidative stress in Parkinson's disease
Subramaniam, S. R., & Chesselet, M.-F. (2013) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.04.004 · Cited by 913
The function of α-synuclein
Bendor, J. T., Logan, T. P., & Edwards, R. H. (2013) · Neuron · doi:10.1016/j.neuron.2013.09.004 · Cited by 825
Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain
Sofic, E., Riederer, P., Heinsen, H., Beckmann, H., Reynolds, G. P., Hebenstreit, G., & Youdim, M. B. H. (1988) · Journal of Neural Transmission · doi:10.1007/bf01244786 · Cited by 752
cDNA cloning of human liver monoamine oxidase A and B: molecular basis of differences in enzymatic properties.
Bach, A. W., Lan, N. C., Johnson, D. L., Abell, C. W., Bembenek, M. E., Kwan, S. W., Seeburg, P. H., & Shih, J. C. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.13.4934 · Cited by 723
Dopamine covalently modifies and functionally inactivates parkin
LaVoie, M. J., Ostaszewski, B. L., Weihofen, A., Schlossmacher, M. G., & Selkoe, D. J. (2005) · Nature Medicine · doi:10.1038/nm1314 · Cited by 722
Electrochemical Studies of the Oxidation Pathways of Catecholamines
Hawley, M. D., Tatawawadi, S. V., Piekarski, S., & Adams, R. N. (1967) · Journal of the American Chemical Society · doi:10.1021/ja00978a051 · Cited by 657
Mitochondrial dysfunction in Parkinson's disease: molecular mechanisms and pathophysiological consequences
Exner, N., Lutz, A. K., Haass, C., & Winklhofer, K. F. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.170 · Cited by 642
Profound neuronal plasticity in response to inactivation of the dopamine transporter
Jones, S. R., Gainetdinov, R. R., Jaber, M., Giros, B., Wightman, R. M., & Caron, M. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.4029 · Cited by 600
A timeline for Parkinson's disease
Hawkes, C. H., Del Tredici, K., & Braak, H. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.08.007 · Cited by 594
Anatomy, pigmentation, ventral and dorsal subpopulations of the substantia nigra, and differential cell death in Parkinson's disease.
Gibb, W. R., & Lees, A. J. (1991) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.54.5.388 · Cited by 574
Identification of a Novel LRRK2 Mutation Linked to Autosomal Dominant Parkinsonism: Evidence of a Common Founder across European Populations
Kachergus, J., Mata, I. F., Hulihan, M., Taylor, J. P., Lincoln, S., Aasly, J., Gibson, J. M., Ross, O. A., Lynch, T., Wiley, J., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/429256 · Cited by 541
A Wide Variety of Mutations in the Parkin Gene Are Responsible for Autosomal Recessive Parkinsonism in Europe
Abbas, N., Lucking, C. B., Ricard, S., Durr, A., Bonifati, V., De Michele, G., Bouley, S., Vaughan, J. R., Gasser, T., Marconi, R., et al. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.4.567 · Cited by 530
Chemistry of Mixed Melanogenesis—Pivotal Roles of Dopaquinone†
Ito, S., & Wakamatsu, K. (2008) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2007.00238.x · Cited by 503
Mitochondrial dysfunction and oxidative stress in Parkinson's disease and monogenic parkinsonism
Hauser, D. N., & Hastings, T. G. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.10.011 · Cited by 474
Cytotoxic and genotoxic potential of dopamine
Stokes, A. H., Hastings, T. G., & Vrana, K. E. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990315)55:6<659::aid-jnr1>3.0.co;2-c · Cited by 469
Advances in the genetics of Parkinson disease
Trinh, J., & Farrer, M. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2013.132 · Cited by 466
Structures for amyloid fibrils
Makin, O. S., & Serpell, L. C. (2005) · The FEBS Journal · doi:10.1111/j.1742-4658.2005.05025.x · Cited by 461
Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease
Banati, R. B., Daniel, S. E., & Blunt, S. B. (1998) · Movement Disorders · doi:10.1002/mds.870130205 · Cited by 431
Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study
Good, P. F., Olanow, C. W., & Perl, D. P. (1992) · Brain Research · doi:10.1016/0006-8993(92)91334-b · Cited by 427
Untitled work
(1999) · PubMed · Cited by 425
Potential oxidative pathways of brain catecholamines
Tse, D. C. S., McCreery, R. L., & Adams, R. N. (1976) · Journal of Medicinal Chemistry · doi:10.1021/jm00223a008 · Cited by 415
Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles
Sulzer, D., Bogulavsky, J., Larsen, K. E., Behr, G., Karatekin, E., Kleinman, M. H., Turro, N., Krantz, D., Edwards, R. H., Greene, L. A., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.22.11869 · Cited by 407
Self-citation
Iron, Neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages: consequences for iron storage and neurodegenerative processes
Zecca, L., Gallorini, M., Schünemann, V., Trautwein, A. X., Gerlach, M., Riederer, P., Vezzoni, P., & Tampellini, D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00186.x · Cited by 401
Increased monoamine oxidase b activity in plaque-associated astrocytes of Alzheimer brains revealed by quantitative enzyme radioautography
Saura, J., Luque, J. M., Cesura, A. M., Prada, M. D., Chan-Palay, V., Huber, G., Löffler, J., & Richards, J. G. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90311-5 · Cited by 382
Loss of the Parkinson's disease-linked gene DJ-1 perturbs mitochondrial dynamics
Irrcher, I., Aleyasin, H., Seifert, E. L., Hewitt, S. J., Chhabra, S., Phillips, M., Lutz, A. K., Rousseaux, M. W. C., Bevilacqua, L., Jahani-Asl, A., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddq288 · Cited by 382
Enzymatic Oxidation of Dopamine: The Role of Prostaglandin H Synthase
Hastings, T. G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020919.x · Cited by 359
Localization of distinct monoamine oxidase a and monoamine oxidase b cell populations in human brainstem
Westlund, K. N., Denney, R. M., Rose, R. M., & Abell, C. W. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90250-3 · Cited by 354
Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes
BAEZ, S., SEGURA-AGUILAR, J., WIDERSTEN, M., JOHANSSON, A.-S., & MANNERVIK, B. (1997) · Biochemical Journal · doi:10.1042/bj3240025 · Cited by 340
Self-citation
Activation of microglia by human neuromelanin is NF‐κB‐dependent and involves p38 mitogen‐activated protein kinase: implications for Parkinson's disease
Wilms, H., Rosenstiel, P., Sievers, J., Deuschl, G., Zecca, L., & Lucius, R. (2003) · The FASEB Journal · doi:10.1096/fj.02-0314fje · Cited by 337
Self-citation
Iron-melanin complex in substantia nigra of parkinsonian brains: an x-ray microanalysis
Jellinger, K., Kienzl, E., Rumpelmair, G., Riederer, P., Stachelberger, H., Ben‐Shachar, D., & Youdim, M. B. H. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08362.x · Cited by 313
Biochemistry and genetics of monoamine oxidase
Weyler, W., Hsu, Y.-P. P., & Breakafield, X. O. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90064-9 · Cited by 312
Kinetic and Structural Analysis of the Early Oxidation Products of Dopamine
Bisaglia, M., Mammi, S., & Bubacco, L. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610893200 · Cited by 303
Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease
Taylor, J. M., Main, B. S., & Crack, P. J. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.016 · Cited by 303
Selectivity of the Parkinsonian Neurotoxin MPTP: Toxic Metabolite MPP + Binds to Neuromelanin
D'Amato, R. J., Lipman, Z. P., & Snyder, S. H. (1986) · Science · doi:10.1126/science.3080808 · Cited by 296
α‐Synuclein oligomers and clinical implications for Parkinson disease
Kalia, L. V., Kalia, S. K., McLean, P. J., Lozano, A. M., & Lang, A. E. (2013) · Annals of Neurology · doi:10.1002/ana.23746 · Cited by 292
Interaction Between Chemicals and Melanin
LARSSON, B. S. (1993) · Pigment Cell Research · doi:10.1111/j.1600-0749.1993.tb00591.x · Cited by 287
The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease
Zecca, L., Fariello, R., Riederer, P., Sulzer, D., Gatti, A., & Tampellini, D. (2002) · FEBS Letters · doi:10.1016/s0014-5793(01)03269-0 · Cited by 285
Self-citation
Intraneuronal dopamine-quinone synthesis: a review
Sulzer, D., & Zecca, L. (1999) · Neurotoxicity Research · doi:10.1007/bf03033289 · Cited by 284
Self-citation
Formation of a Stabilized Cysteine Sulfinic Acid Is Critical for the Mitochondrial Function of the Parkinsonism Protein DJ-1
Blackinton, J., Lakshminarasimhan, M., Thomas, K. J., Ahmad, R., Greggio, E., Raza, A. S., Cookson, M. R., & Wilson, M. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m806599200 · Cited by 275
Reversible Inhibition of α-Synuclein Fibrillization by Dopaminochrome-mediated Conformational Alterations
Norris, E. H., Giasson, B. I., Hodara, R., Xu, S., Trojanowski, J. Q., Ischiropoulos, H., & Lee, V. M.-Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412621200 · Cited by 273
Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson’s Disease
Zhang, W., Phillips, K., Wielgus, A. R., Liu, J., Albertini, A., Zucca, F. A., Faust, R., Qian, S. Y., Miller, D. S., Chignell, C. F., et al. (2011) · Neurotoxicity Research · doi:10.1007/s12640-009-9140-z · Cited by 257
Self-citation
Protein degradation pathways in Parkinson’s disease: curse or blessing
Ebrahimi-Fakhari, D., Wahlster, L., & McLean, P. J. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1004-6 · Cited by 253
Neuromelanin of the Human Substantia Nigra: An Update
Zucca, F. A., Basso, E., Cupaioli, F. A., Ferrari, E., Sulzer, D., Casella, L., & Zecca, L. (2014) · Neurotoxicity Research · doi:10.1007/s12640-013-9435-y · Cited by 243
Self-citation
New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals
Zecca, L., Bellei, C., Costi, P., Albertini, A., Monzani, E., Casella, L., Gallorini, M., Bergamaschi, L., Moscatelli, A., Turro, N. J., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808768105 · Cited by 240
Dopamine, 6-hydroxydopamine, iron, and dioxygen — their mutual interactions and possible implication in the development of Parkinson's disease
Linert, W., Herlinger, E., Jameson, R. F., Kienzl, E., Jellinger, K., & Youdim, M. B. H. (1996) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(96)00020-8 · Cited by 238
Neuromelanin can protect against iron‐mediated oxidative damage in system modeling iron overload of brain aging and Parkinson’s disease
Zecca, L., Casella, L., Albertini, A., Bellei, C., Zucca, F. A., Engelen, M., Zadlo, A., Szewczyk, G., Zareba, M., & Sarna, T. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05541.x · Cited by 233
Self-citation
Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease
Faucheux, B. A., Martin, M., Beaumont, C., Hauw, J., Agid, Y., & Hirsch, E. C. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01923.x · Cited by 229
Is the Vulnerability of Neurons in the Substantia Nigra of Patients with Parkinson's Disease Related to Their Neuromelanin Content?
Kastner, A., Hirsch, E. C., Lejeune, O., Javoy‐Agid, F., Rascol, O., & Agid, Y. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb08350.x · Cited by 228
Studies on Parkinson's Disease Including X-Ray Fluorescent Spectroscopy of Formalin Fixed Brain Tissue
Earle, K. M. (1968) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-196801000-00001 · Cited by 227
Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson’s disease
Merad-Boudia, M., Nicole, A., Santiard-Baron, D., Saillé, C., & Ceballos-Picot, I. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00647-3 · Cited by 226
Immunochemical Analysis of Vesicular Monoamine Transporter (VMAT2) Protein in Parkinson's Disease
Miller, G. W., Erickson, J. D., Perez, J. T., Penland, S. N., Mash, D. C., Rye, D. B., & Levey, A. I. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.7008 · Cited by 215
Parkinson’s disease: premotor clinico-pathological correlations
Wolters, E. C., & Braak, H. (2006) · Parkinson’s Disease and Related Disorders · doi:10.1007/978-3-211-45295-0_47 · Cited by 215
Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease
Zecca, L., Wilms, H., Geick, S., Claasen, J.-H., Brandenburg, L.-O., Holzknecht, C., Panizza, M. L., Zucca, F. A., Deuschl, G., Sievers, J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0361-7 · Cited by 205
Self-citation
Tyrosine mRNA is expressed in human substantia nigra
Xu, Y., Stokes, A. H., Freeman, W. M., Kumer, S. C., Vogt, B. A., & Vrana, K. E. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(96)00308-7 · Cited by 205
Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease
Goldstein, D. S., Sullivan, P., Holmes, C., Miller, G. W., Alter, S., Strong, R., Mash, D. C., Kopin, I. J., & Sharabi, Y. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12345 · Cited by 202
Protective Actions of the Vesicular Monoamine Transporter 2 (VMAT2) in Monoaminergic Neurons
Guillot, T. S., & Miller, G. W. (2009) · Molecular Neurobiology · doi:10.1007/s12035-009-8059-y · Cited by 201
Role of microtubules and actin filaments in the movement of mitochondria in the axons and dendrites of cultured hippocampal neurons
Ligon, L. A., & Steward, O. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20001120)427:3<351::aid-cne3>3.0.co;2-r · Cited by 195
Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter
Whitehead, R. E., Ferrer, J. V., Javitch, J. A., & Justice, J. B. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00125.x · Cited by 194
On the mechanism of the Mn3+-induced neurotoxicity of dopamine: Prevention of quinone-derived oxygen toxicity by DT diaphorase and superoxide dismutase
Segura-Aguilar, J., & Lind, C. (1989) · Chemico-Biological Interactions · doi:10.1016/0009-2797(89)90006-9 · Cited by 192
Self-citation
Neuronal pigmented autophagic vacuoles: lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease
Sulzer, D., Mosharov, E., Talloczy, Z., Zucca, F. A., Simon, J. D., & Zecca, L. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05385.x · Cited by 191
Self-citation
Iron-binding characteristics of neuromelanin of the human substantia nigra
Double, K. L., Gerlach, M., Schünemann, V., Trautwein, A. X., Zecca, L., Gallorini, M., Youdim, M. B. H., Riederer, P., & Ben-Shachar, D. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00293-4 · Cited by 181
Self-citation
Point Mutations (Thr240Arg and Ala311Stop) in theParkinGene
Hattori, N., Matsumine, H., Asakawa, S., Kitada, T., Yoshino, H., Elibol, B., Brookes, A. J., Yamamura, Y., Kobayashi, T., Wang, M., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9134 · Cited by 181
Dopamine, in the presence of tyrosinase, covalently modifies and inactivates tyrosine hydroxylase
Xu, Y., Stokes, A. H., Roskoski, R., & Vrana, K. E. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19981201)54:5<691::aid-jnr14>3.0.co;2-f · Cited by 175
The structure of neuromelanin as studied by chemical degradative methods
Wakamatsu, K., Fujikawa, K., Zucca, F. A., Zecca, L., & Ito, S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01917.x · Cited by 172
Self-citation
Iron and Other Metals in Neuromelanin, Substantia Nigra, and Putamen of Human Brain
Zecca, L., Pietra, R., Goj, C., Mecacci, C., Radice, D., & Sabbioni, E. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62031097.x · Cited by 163
Self-citation
Whole-Body Lifetime Occupational Lead Exposure and Risk of Parkinson’s Disease
Coon, S., Stark, A., Peterson, E., Gloi, A., Kortsha, G., Pounds, J., Chettle, D., & Gorell, J. (2006) · Environmental Health Perspectives · doi:10.1289/ehp.9102 · Cited by 161
The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface
Bush, W. D., Garguilo, J., Zucca, F. A., Albertini, A., Zecca, L., Edwards, G. S., Nemanich, R. J., & Simon, J. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604010103 · Cited by 159
Self-citation
α-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease
Mullin, S., & Schapira, A. H. V. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8394-x · Cited by 159
Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species
Fornstedt, B., Rosengren, E., & Carlsson, A. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90242-x · Cited by 156
Proteomic identification of dopamine-conjugated proteins from isolated rat brain mitochondria and SH-SY5Y cells
Laar, V. S. V., Mishizen-Eberz, A. J., Cascio, M., & Hastings, T. G. (2009) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.03.004 · Cited by 154
Oxidation Chemistry of Catecholamines and Neuronal Degeneration: An Update
Napolitano, A., Manini, P., & d’Ischia, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795496863 · Cited by 153
Detection of 5-S-cysteinyldopamine in human brain
Rosengren, E., Linder-Eliasson, E., & Carlsson, A. (1985) · Journal of Neural Transmission · doi:10.1007/bf01252029 · Cited by 152
Prostaglandin H Synthetase‐Mediated Metabolism of Dopamine: Implication for Parkinson's Disease
Mattammal, M. B., Strong, R., Lakshmi, V. M., Chung, H. D., & Stephenson, A. H. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64041645.x · Cited by 151
Regulation of dopamine transporter function by protein‐protein interactions: new discoveries and methodological challenges
Eriksen, J., Jørgensen, T. N., & Gether, U. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06599.x · Cited by 148
Neuromelanin and Parkinson's disease.
MARSDEN, C. D. (1983) · PubMed · Cited by 144
The neuromelanin of the human substantia nigra
Carstam, R., Brinck, C., Hindemith, A., Rorsman, H., & Rosengren, E. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(91)90100-n · Cited by 143
A Biochemical and Functional Protein Complex Involving Dopamine Synthesis and Transport into Synaptic Vesicles
Cartier, E. A., Parra‐Rivas, L. A., Baust, T. B., Quiroz, M. E., Salazar, G., Faúndez, V., Egaña, L. A., & Torres, G. E. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.054510 · Cited by 141
Structure and Function of Parkin, PINK1, and DJ-1, the Three Musketeers of Neuroprotection
Trempe, J., & Fon, E. A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00038 · Cited by 137
Binding of Iron to Neuromelanin of Human Substantia Nigra and Synthetic Melanin: An Electron Paramagnetic Resonance Spectroscopy Study
Shima, T., Sarna, T., Swartz, H. M., Stroppolo, A., Gerbasi, R., & Zecca, L. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00623-5 · Cited by 135
Self-citation
Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effects
Segura‐Aguilar, J., Metodiewa, D., & Welch, C. J. (1998) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(98)00036-1 · Cited by 131
Self-citation
The effect of a synthetic neuromelanin on yield of free hydroxyl radicals generated in model systems
Zaręba, M., Bober, A., Korytowski, W., Zecca, L., & Sarna, T. (1995) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(95)00058-c · Cited by 131
Self-citation
On the Nature of Pigment Granules in the Cells of the Locus Coeruleus and Substantia Nigra
Foley, J. M., & Banter, D. (1958) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-195810000-00005 · Cited by 129
Copper neurotoxicity is dependent on dopamine‐mediated copper uptake and one‐electron reduction of aminochrome in a rat substantia nigra neuronal cell line
Paris, I. B., Dagnino‐Subiabre, A., Marcelain, K., Bennett, L. B., Caviedes, P. A., Caviedes, R., Olea‐Azar, C., & Segura‐Aguilar, J. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00243.x · Cited by 129
Self-citation
Human Class Mu Glutathione Transferases, in Particular Isoenzyme M2-2, Catalyze Detoxication of the Dopamine Metabolite Aminochrome
Segura‐Aguilar, J., Baez, S., Widersten, M., Welch, C. J., & Mannervik, B. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5727 · Cited by 128
Self-citation
A Potential Role for Cyclized Quinones Derived from Dopamine, DOPA, and 3,4-Dihydroxyphenylacetic Acid in Proteasomal Inhibition
Zafar, K. S., Siegel, D. M., & Ross, D. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.024703 · Cited by 124
Tyrosinase exacerbates dopamine toxicity but is not genetically associated with Parkinson's disease
Greggio, E., Bergantino, E., Carter, D., Ahmad, R., Costin, G., Hearing, V. J., Clarimón, J., Singleton, A., Eerola, J., Hellström, O., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03019.x · Cited by 123
On the neurotoxicity mechanism of leukoaminochrome o-semiquinone radical derived from dopamine oxidation: mitochondria damage, necrosis, and hydroxyl radical formation
Arriagada, C., Paris, I. B., Matas, M. J. S. D. L., Martinez-Alvarado, P., Cárdenas, S., Castañeda, P., Graumann, R., Perez-Pastene, C., Olea‐Azar, C., Couve, E., et al. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.03.014 · Cited by 123
Self-citation
Modifications of the iron–neuromelanin system in Parkinson's disease
Fasano, M., Bergamasco, B., & Lopiano, L. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03638.x · Cited by 117
Catecholamines oxidation by xanthine oxidase
Foppoli, C., Coccia, R., Cini, C., & Rosei, M. A. (1997) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(96)00093-1 · Cited by 117
Glutathione Transferase M2-2 Catalyzes Conjugation of Dopamine and Dopa o-Quinones
Dagnino‐Subiabre, A., Cassels, B. K., Baez, S., Johansson, A.-S., Mannervik, B., & Segura‐Aguilar, J. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3087 · Cited by 117
Self-citation
Molecular basis of human MAO A and B.
Shih, J. (1991) · PubMed · Cited by 117
Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: Accumulation in neuromelanin
Lindquist, N. G., Larsson, B. S., & Lydén‐Sokolowski, A. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90002-x · Cited by 115
Analysis of Conserved Active Site Residues in Monoamine Oxidase A and B and Their Three-dimensional Molecular Modeling
Geha, R. M., Chen, K., Wouters, J., Ooms, F., & Shih, J. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110920200 · Cited by 112
Intracellular Chemical Imaging of the Developmental Phases of Human Neuromelanin Using Synchrotron X-ray Microspectroscopy
Bohic, S., Murphy, K., Paulus, W., Cloetens, P., Salome-Pateyron, M., Susini, J., & Double, K. L. (2008) · Analytical Chemistry · doi:10.1021/ac801817k · Cited by 111
Irreversible Inhibition of Mitochondrial Complex I by 7‐(2‐Aminoethyl)‐3,4‐Dihydro‐5‐Hydroxy‐2H‐1,4‐Benzothiazine‐3‐Carboxylic Acid (DHBT‐1): A Putative Nigral Endotoxin of Relevance to Parkinson's Disease
Li, H., & Dryhurst, G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041530.x · Cited by 109
Proteomic analysis of rat brain mitochondria following exposure to dopamine quinone: Implications for Parkinson disease
Laar, V. S. V., Dukes, A. A., Cascio, M., & Hastings, T. G. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.11.007 · Cited by 109
Distribution of catechol‐ O ‐methyltransferase (COMT) proteins and enzymatic activities in wild‐type and soluble COMT deficient mice
Myöhänen, T. T., Schendzielorz, N., & Männistö, P. T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06723.x · Cited by 108
Influence of neuromelanin on oxidative pathways within the human substantia nigra
Double, K. L., Ben-Shachar, D., Youdim, M. B. H., Zecca, L., Riederer, P., & Gerlach, M. (2002) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(02)00218-0 · Cited by 102
Self-citation
Chemical intermediates in dopamine oxidation by tyrosinase, and kinetic studies of the process
Jiménez, M. I., García‐Carmona, F., Garcı́a-Cánovas, F., Iborra, J. L., Lozano, J. A., & Martinez, F. (1984) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(84)90217-0 · Cited by 98
“Subcellular Proteomics” of Neuromelanin Granules Isolated from the Human Brain
Tribl, F., Gerlach, M., Marcus, K., Asan, E., Tatschner, T., Arzberger, T., Meyer, H. E., Bringmann, G., & Riederer, P. F. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m400117-mcp200 · Cited by 98
Interaction of Human Substantia Nigra Neuromelanin with Lipids and Peptides
Zecca, L., Costi, P., Mecacci, C., Ito, S., Terreni, M., & Sonnino, S. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0741758.x · Cited by 95
Self-citation
Dopamine Inactivates Tryptophan Hydroxylase and Forms a Redox-Cycling Quinoprotein: Possible Endogenous Toxin to Serotonin Neurons
Kuhn, D. M., & Arthur, R. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-18-07111.1998 · Cited by 91
Aminochrome Induces Disruption of Actin, Alpha-, and Beta-Tubulin Cytoskeleton Networks in Substantia-Nigra-Derived Cell Line
Paris, I. B., Perez-Pastene, C., Cárdenas, S., Iturra, P., Muñoz, P., Couve, E., Caviedes, P. A., & Segura‐Aguilar, J. (2010) · Neurotoxicity Research · doi:10.1007/s12640-009-9148-4 · Cited by 90
Self-citation
Distribution of dt diaphorase in the rat brain: Biochemical and immunohistochemical studies
Schultzberg, M., Segura-Aouilar, J., & Lind, C. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90181-9 · Cited by 88
Molecular characterization of dopamine-derived quinones reactivity toward NADH and glutathione: Implications for mitochondrial dysfunction in Parkinson disease
Bisaglia, M., Soriano, M. E., Arduini, I., Mammi, S., & Bubacco, L. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.06.006 · Cited by 88
Dopamine quinone modifies and decreases the abundance of the mitochondrial selenoprotein glutathione peroxidase 4
Hauser, D. N., Dukes, A. A., Mortimer, A. D., & Hastings, T. G. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.06.030 · Cited by 87
Orientation and Cellular Distribution of Membrane-bound Catechol-O-methyltransferase in Cortical Neurons
Chen, J., Song, J., Yuan, P., Tian, Q., Ji, Y., Ren‐Patterson, R. F., Liu, G., Sei, Y., & Weinberger, D. R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.262790 · Cited by 85
Neuromelanins of Human Brain Have Soluble and Insoluble Components with Dolichols Attached to the Melanic Structure
Engelen, M., Vanna, R., Bellei, C., Zucca, F. A., Wakamatsu, K., Monzani, E., Ito, S., Casella, L., & Zecca, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048490 · Cited by 79
Self-citation
Inhibition of VMAT-2 and DT-Diaphorase Induce Cell Death in a Substantia Nigra-Derived Cell LineAn Experimental Cell Model for Dopamine Toxicity Studies
Fuentes, P., Paris, I. B., Nassif, M., Caviedes, P. A., & Segura‐Aguilar, J. (2007) · Chemical Research in Toxicology · doi:10.1021/tx600325u · Cited by 77
Self-citation
Autophagy Protects Against Aminochrome-Induced Cell Death in Substantia Nigra-Derived Cell Line
Paris, I. B., Muñoz, P., Huenchuguala, S., Couve, E., Sanders, L. H., Greenamyre, J. T., Caviedes, P. A., & Segura‐Aguilar, J. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfr060 · Cited by 75
Self-citation
Dopamine-Dependent Iron Toxicity in Cells Derived from Rat Hypothalamus
Paris, I., Martinez-Alvarado, P., Cárdenas, S., Perez-Pastene, C., Graumann, R., Fuentes, P., Olea-Azar, C., Caviedes, P., & Segura-Aguilar, J. (2005) · Chemical Research in Toxicology · doi:10.1021/tx0497144 · Cited by 74
Self-citation
Does tyrosinase exist in neuromelanin-pigmented neurons in the human substantia nigra?
Ikemoto, K., Nagatsu, I., Ito, S., King, R. A., Nishimura, A., & Nagatsu, T. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00649-1 · Cited by 74
Recombinant Cytochrome P450 2D18 Metabolism of Dopamine and Arachidonic Acid
Thompson, C. M., Capdevila, J. H., & Strobel, H. W. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39180-3 · Cited by 74
Superoxide Dismutase and Catalase Enhance Autoxidation during One-Electron Reduction of Aminochrome by NADPH-Cytochrome P-450 Reductase
Baez, S., Linderson, Y., & Segura‐Aguilar, J. (1995) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1995.1002 · Cited by 71
Self-citation
Elevated 5-S-cysteinyldopamine/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: possible markers for and potential insights into the pathoetiology of Parkinson's disease
Cheng, F. C., Kuo, J. S., Chia, L. G., & Dryhurst, G. (1996) · Journal of Neural Transmission · doi:10.1007/bf01276419 · Cited by 70
Copper·Dopamine Complex Induces Mitochondrial Autophagy Preceding Caspase-independent Apoptotic Cell Death
Paris, I. B., Perez-Pastene, C., Couve, E., Caviedes, P. A., LeDoux, S. P., & Segura‐Aguilar, J. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900323200 · Cited by 70
Self-citation
Neuromelanin induces oxidative stress in mitochondria through release of iron: mechanism behind the inhibition of 26S proteasome
Shamoto‐Nagai, M., Maruyama, W., Yi, H. L., Akao, Y., Tribl, F., Gerlach, M., Osawa, T., Riederer, P. F., & Naoi, M. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0410-5 · Cited by 67
Synthesis, Redox Properties,in VivoFormation, and Neurobehavioral Effects ofN-Acetylcysteinyl Conjugates of Dopamine: Possible Metabolites of Relevance to Parkinson's Disease
Shen, X.-M., Xia, B., Wrona, M. Z., & Dryhurst, G. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960052v · Cited by 67
Glutathione transferase mu 2 protects glioblastoma cells against aminochrome toxicity by preventing autophagy and lysosome dysfunction
Huenchuguala, S., Muñoz, P., Zavala, P., Villa, M., Cuevas, C., Ahumada, U., Graumann, R., Nore, B. F., Couve, E., Mannervik, B., et al. (2014) · Autophagy · doi:10.4161/auto.27720 · Cited by 65
Self-citation
Dolichol is the major lipid component of human substantia nigra neuromelanin
Fedorow, H., Pickford, R., Hook, J. M., Double, K. L., Halliday, G. M., Gerlach, M., Riederer, P. F., & Garner, B. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02975.x · Cited by 64
Encapsulation of a reactive core in neuromelanin
Ito, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606879103 · Cited by 64
Dopamine (DA) induced irreversible proteasome inhibition via DA derived quinones
Zhou, Z., & Lim, T. M. (2009) · Free Radical Research · doi:10.1080/10715760902801533 · Cited by 61
Biosynthetic pathway to neuromelanin and its aging process
Wakamatsu, K., Murase, T., Zucca, F. A., Zecca, L., & Ito, S. (2012) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12014 · Cited by 60
Self-citation
Genetic causes of Parkinson?s disease: UCHL-1
Healy, D. G., Abou‐Sleiman, P. M., & Wood, N. W. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0917-3 · Cited by 57
Human neuromelanin an endogenous microglial activator for dopaminergic neuron death
Zhang, W. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e591 · Cited by 54
Behavioral effects of manganese injected in the rat substantia nigra are potentiated by dicumarol, a DT-diaphorase inhibitor
Díaz‐Véliz, G. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.10.016 · Cited by 52
Melanin affinity and its possible role in neurodegeneration
Karlsson, O., & Lindquist, N. G. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1062-5 · Cited by 52
Enzymatic dopamine peroxidation in substantia nigra of human brain
Galzigna, L., Iuliis, A. D., & Zanatta, L. (2000) · Clinica Chimica Acta · doi:10.1016/s0009-8981(00)00313-2 · Cited by 51
Overexpression of VMAT-2 and DT-diaphorase protects substantia nigra-derived cells against aminochrome neurotoxicity
Muñoz, P., Paris, I. B., Sanders, L. H., Greenamyre, J. T., & Segura‐Aguilar, J. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.03.010 · Cited by 51
Self-citation
Monoamine transporter inhibitors and norepinephrine reduce dopamine‐dependent iron toxicity in cells derived from the substantia nigra
Paris, I. B., Martinez-Alvarado, P., Perez-Pastene, C., Vieira, M. N. N., Olea‐Azar, C., Raisman‐Vozari, R., Cárdenas, S., Graumann, R. T., Caviedes, P. A., & Segura‐Aguilar, J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02931.x · Cited by 50
Self-citation
Alpha-synuclein and protein degradation pathways in Parkinson's disease: A pathological feed-back loop
Martínez‐Vicente, M., & Vila, M. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2013.03.005 · Cited by 50
Neuromelanin inhibits enzymatic activity of 26S proteasome in human dopaminergic SH-SY5Y cells
Shamoto‐Nagai, M., Maruyama, W., Akao, Y., Osawa, T., Tribl, F., Gerlach, M., Zucca, F. A., Zecca, L., Riederer, P. F., & Naoi, M. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0211-2 · Cited by 49
Self-citation
Stable Expression of Short Interfering RNA for DT-Diaphorase Induces Neurotoxicity
Lozano, J., Muñoz, P., Nore, B. F., LeDoux, S. P., & Segura‐Aguilar, J. (2010) · Chemical Research in Toxicology · doi:10.1021/tx100182a · Cited by 49
Self-citation
Tyrosinase is not detected in human catecholaminergic neurons by immunohistochemistry and Western blot analysis
Tribl, F., Arzberger, T., Riederer, P. F., & Gerlach, M. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_8 · Cited by 48
Neuroprotective profile of the multitarget drug rasagiline in Parkinson's disease
Weinreb, O., Amit, T., Riederer, P. F., Youdim, M. B. H., & Mandel, S. A. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-386467-3.00007-8 · Cited by 47
Peroxidase Activity of Liver Microsomal Vitamin D 25-Hydroxylase and Cytochrome P450 1A2 Catalyzes 25-Hydroxylation of Vitamin D3and Oxidation of Dopamine to Aminochrome
Segura‐Aguilar, J. (1996) · Biochemical and Molecular Medicine · doi:10.1006/bmme.1996.0039 · Cited by 44
Self-citation
l ‐DOPA Is a Substrate for Tyrosine Hydroxylase
Haavik, J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041720.x · Cited by 44
Neuromelanin and its Possible Protective and Destructive Properties
Lindquist, N. G., LARSSON, B. S., & Lydén‐Sokolowski, A. (1987) · Pigment Cell Research · doi:10.1111/j.1600-0749.1987.tb00403.x · Cited by 41
Chemical, Pulse Radiolysis and Density Functional Studies of a New, Labile 5,6-Indolequinone and Its Semiquinone
Pezzella, A., Crescenzi, O., Natangelo, A., Panzella, L., Napolitano, A., Navaratnam, S., Edge, R., Land, E. J., Barone, V., & d’Ischia, M. (2007) · The Journal of Organic Chemistry · doi:10.1021/jo0615807 · Cited by 39
A Molecular Dynamics Simulation-Based Interpretation of Nuclear Magnetic Resonance Multidimensional Heteronuclear Spectra of α-Synuclein·Dopamine Adducts
Dibenedetto, D., Rossetti, G., Caliandro, R., & Carloni, P. (2013) · Biochemistry · doi:10.1021/bi400367r · Cited by 39
Catechol amine oxidation and ionization properties indicated from the hydrogen ion release, tritium exchange, and spectral changes which occur during ferricyanide oxidation
Harrison, W., Whisler, W. W., & Hill, B. J. (1968) · Biochemistry · doi:10.1021/bi00849a010 · Cited by 39
Binding of dopaminergic drugs by the neuromelanin of the substantia nigra, synthetic melanins and melanin granules.
Salazar, M. M., Td, S., & Pn, P. (1978) · PubMed · Cited by 35
Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis
Ferrari, E., Engelen, M., Monzani, E., Sturini, M., Girotto, S., Bubacco, L., Zecca, L., & Casella, L. (2012) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-012-0951-7 · Cited by 34
Self-citation
Identification and quantification of dolichol and dolichoic acid in neuromelanin from substantia nigra of the human brain
Ward, W. C., Guan, Z., Zucca, F. A., Fariello, R. G., Kordestani, R., Zecca, L., Raetz, C. R. H., & Simon, J. D. (2007) · Journal of Lipid Research · doi:10.1194/jlr.c700008-jlr200 · Cited by 33
Self-citation
Myoglobin Modification by Enzyme‐Generated Dopamine Reactive Species
Nicolis, S., Zucchelli, M., Monzani, E., & Casella, L. (2008) · Chemistry - A European Journal · doi:10.1002/chem.200801014 · Cited by 29
Characterization of reduced and oxidized dopamine and 3,4-dihydrophenylacetic acid, on brain mitochondrial electron transport chain activities
Gautam, A. H., & Zeevalk, G. D. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.03.013 · Cited by 28
Quinoprotein Adducts Accumulate in the Substantia Nigra of Aged Rats and Correlate with Dopamine-Induced Toxicity in SH-SY5Y Cells
Wang, N., Wang, Y., Yu, G., Yuan, C., & Ma, J. (2011) · Neurochemical Research · doi:10.1007/s11064-011-0541-z · Cited by 26
Sulphydryl compounds in melanogenesis
d’Ischia, M., Napolitano, A., & Prota, G. (1987) · Tetrahedron · doi:10.1016/s0040-4020(01)87713-9 · Cited by 25
Inhibition of DT-diaphorase is a requirement for Mn3+ to produce a 6-OH-dopamine like rotational behaviour
Segura‐Aguilar, J., Díaz‐Véliz, G., Mora, S., & Herrera‐Marschitz, M. (2002) · Neurotoxicity Research · doi:10.1080/10298420290015926 · Cited by 25
Self-citation
Copper Neurotoxicity in Rat Substantia Nigra and Striatum Is Dependent on DT-Diaphorase Inhibition
Díaz‐Véliz, G., Paris, I. B., Mora, S., Raisman‐Vozari, R., & Segura‐Aguilar, J. (2008) · Chemical Research in Toxicology · doi:10.1021/tx8001143 · Cited by 24
Self-citation
Molecular Biology of Monoamine Oxidase A and B: Their Role in the Degradation of Serotonin
Shih, J. C., Grimsby, J. S., & Chen, K. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-60921-3_25 · Cited by 23
Catechol-O-Methyltransferase Inhibitors in Preclinical Models as Adjuncts of l-Dopa Treatment
Marín, C., & Obeso, J. A. (2010) · International review of neurobiology · doi:10.1016/b978-0-12-381326-8.00008-9 · Cited by 21
Neurons inflict self-harm
Cookson, M. (2005) · Nature Medicine · doi:10.1038/nm1105-1159 · Cited by 19
Targeting Alpha-Synuclein for the Treatment of Parkinson's Disease
Rohn, T. T. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800269678 · Cited by 17
Combined biochemical separation and INAA for the determination of iron and other metals in Neuromelanin of human brain Substantia Nigra
Zecca, L., Tampellini, D., Costi, P., Rizzio, E., Giaveri, G., & Gallorini, M. (2001) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1023/a:1013251510671 · Cited by 8
Self-citation
Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure
Langston, J. W., Forno, L. S., Tetrud, J., Reeves, A. G., Kaplan, J. A., & Karluk, D. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199910)46:4 · Cited by 1

Dopamine: Functions, Signaling, and Association with Neurological Diseases
Klein, M. O., Battagello, D. S., Cardoso, A. R., Hauser, D. N., Bittencourt, J. C., & Correa, R. G. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0632-3 · Cited by 1,073
Oxidative stress and Parkinson’s disease
Blesa, J., Trigo-Damas, I., Quiroga-Varela, A., & Jackson-Lewis, V. R. (2015) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2015.00091 · Cited by 878
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Zucca, F. A., Segura-Aguilar, J., Ferrari, E., Muñoz, P., Paris, I., Sulzer, D., Sarna, T., Casella, L., & Zecca, L. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.09.012 · Cited by 659
Self-citation
Covalent Modifiers: A Chemical Perspective on the Reactivity of α,β-Unsaturated Carbonyls with Thiols via Hetero-Michael Addition Reactions
Jackson, P. A., Widen, J. C., Harki, D. A., & Brummond, K. M. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00788 · Cited by 588
Formation and Biological Targets of Quinones: Cytotoxic versus Cytoprotective Effects
Bolton, J. L., & Dunlap, T. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00256 · Cited by 522

See all 498

Authors: Segura‐Aguilar, J., Paris, I., Muñoz, P., Ferrari, E., Zecca, L., & Zucca, F. A.
Venue: Journal of Neurochemistry
Publisher: Wiley
Published: 2014-03-18
Volume: 129
Issue: 6
Pages: 898-915
ISSN: 0022-3042 (ISSN-L)
1471-4159
DOI: 10.1111/jnc.12686
OpenAlex: W2000293969
Cited by: 498
References: 174
FWCI: 18.63
Type: journal article
Language: en
Open access: green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Protective and toxic roles of dopamine in Parkinson's disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

Data sources